Innovations and programs advance $1B oncology commitment

ME Newswire / Business Wire

CHALFONT ST. GILES, UK - Monday, February 4th 2013

GE Healthcare’s work to accelerate cancer innovation and improve care for cancer patients reached new milestones in advanced technology.

The campaign is founded on GE Healthcare’s integrated portfolio, which is uniquely positioned to drive impact in oncology and a leap forward for individualized cancer care. GE Healthcare launched a series of new oncology technologies and systems to help advance cancer diagnostic and molecular imaging in 2012.

"At GE, we are committed to the ongoing fight against cancer, the leading cause of death worldwide,” said John Dineen, president and CEO, GE Healthcare. "I’m proud of the investment and innovations that we’ve made over the past year and look forward to working with our customers and partners to develop new technologies and oncology solutions. We fully support World Cancer Day o ... Read more »

DOZ facilitates growth of outsource industry in Dubai
Dubai, United Arab Emirates - Monday, February 4th 2013 [ME NewsWire]

Just over a year since its inauguration as a business partner of Dubai Outsource Zone (DOZ), business process management company Genpact has doubled its presence in the UAE.

The news follows a successful year for the organization which has increased its client portfolio from just two in late 2011, to 13 including Mashreq Bank, IFFCO, Mubadala GE Capital, and the Tourism Development & Investment Company, according to Genpact President and CEO, Tiger Tyagarajan, who visited Dubai on 3rd February.

Speaking after a meeting with Mr Tyagarajan in Dubai Internet City, Malek Al Malek, Managing Director of Dubai Internet City and Dubai Outsource Zone said:  "The UAE is migrating from being a regional support to becoming a regional hub for the business process management industry. Our latest white paper ‘Outsourcing in the MENA Region’ revea ... Read more »

Dubai, United Arab Emirates - Monday, February 4th 2013 [ME NewsWire]

(BUSINESS WIRE)-- MMFX Steel DMCC (www.mmfx.com) announced today that the International Code Council Evaluation Service (ICC-ES) has issued Evaluation Report ESR-2107 for MMFX2, an uncoated corrosion-resistant and high-strength reinforcing steel. The report provides design guidance for using MMFX2 ASTM A1035 high-strength reinforcing steel up to 690 ksi beyond the current ACI 318 limitations from the American Concrete Institute (ACI).

The ESR-2107 report demonstrates how MMFX2 ASTM A1035 Grade 100 (690 MPa) complies with all applicable areas of the 2012 and 2009 International Building Code® (IBC). The report provides engineers and building officials a verified guide on how to specify, approve and properly take advantage of the high-strength benefits of MMFX2 reinforcing steel.

"MMFX2 reinforcing steel offers engineers, construction contractors and owners a high-strength rebar solution to redu ... Read more »

L’Olodaterol représente une nouvelle alternative médicale pour les patients atteints de la BPCO

Dubaï, Émirats Arabes Unis - Lundi 4 Février 2013 [ME NewsWire]

Boehringer Ingelheim a annoncé que la  U.S. Food and Drug Administration (FDA) et le Pulmonary-Allergy Drugs Advisory Committee (PADAC), ont approuvé  les données cliniques figurant  dans  la demande d’enregistrement, qui offrent des preuves importantes et convaincantes pour soutenir l’approbation de l’olodaterol à raison d’une fois par jour comme traitement bronchodilatateur  de l’obstruction des voies respiratoires chez les patients atteints de Broncho-pneumopathie chronique obstructive (BPCO), y compris la bronchite chronique etou l’emphysème. 1A,B,C  

Le professeur Klaus Dugi, vice-président  des affaires  médicales  chez Boehringer Ingelheim, a déclaré, « Nous nous réjouissons ... Read more »

SKIEN, Norway - Monday, February 4th 2013 [ME NewsWire]

(BUSINESS WIRE)-- The Ibsen Scholarships award innovative projects in the field of drama and performing arts that act as incentives for critical discourse in regards to existential and society-related subject matters concerning Henrik Ibsen and his plays.

Scholarship funds amount to NOK 1,000,000,- (approx. 135.000 Euro/180.000 US Dollars) will be awarded projects worldwide.

Scholarships are applicable to individuals, organizations or institutions within the artistic and cultural community.

The Ibsen Scholarships are awarded annually and the applications are subject to scrutiny by an appointed jury.

The Ibsen Scholarships were initiated by the Norwegian government and will be handed out for the 6th time in 2013.

Ibsen Awards has till now handed out 19 scholarships to projects in 15 different countries.

The application deadline for The Ibsen Scholarships is April 30th 2013.

Th ... Read more »

JEDDAH, Saudi Arabia - Monday, February 4th 2013 [ME NewsWire]

( ... Read more »

Olodaterol may provide a new treatment option in patients with COPD

Dubai, United Arab Emirates - Monday, February 4th 2013 [ME NewsWire]

Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) recommendedthat clinical data included in a new drug application (NDA) provide substantial and convincing evidence to support the approval of olodaterol as a once-daily maintenance bronchodilator treatment for airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.1A,B,C  

"We at Boehringer Ingelheim are pleased with the Advisory Committee’s recommendation and look forward to continuing to work with the FDA as the Agency continues its review of the olodaterol NDA,” said Professor Klaus Dugi, Corporate Senior Vice President Medicine at Boehringer Ingelheim. "The positive vote from the Advisory Committee marks an important st ... Read more »

V. Raman Kumar, founder and former CEO of MModal, has made a strategic investment and will join the Board as Vice Chairman


WATERLOO, Ontario - Monday, February 4th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Vestec, Inc.a leader in cutting-edge Artificial Intelligence technologies, today announced that they have secured a $1.5 million equity investment from V. Raman Kumar, founder and former CEO of MModal, the world’s largest clinical documentation company and pioneer of voice-based medical transcription.

Mr. Kumar has joined Vestec’s Board of Directors as Vice Chairman and will also oversee the development of products and services for the global industry with a special focus on healthcare.

"Natural language understanding applications represent the next frontier in healthcare,” said Dr. Fakhri Karray, Vestec’s primary Founder and Chairman. "We are very happy Raman will be contributing his considerable expertise and relationships to our team.”

"I am deli ... Read more »